Activation of the NLRP3 inflammasome by CCl4 exacerbates hepatopathogenic diet-induced experimental NASH-Reference-Cited by-同舟云学术

Activation of the NLRP3 inflammasome by CCl4 exacerbates hepatopathogenic diet-induced experimental NASH

Published:2023-01 Issue:1 Volume:28 Page:100780
ISSN:1665-2681
Container-title:Annals of Hepatology
language:en
Short-container-title:Annals of Hepatology

Author:

Vargas-Pozada Eduardo E.,Ramos-Tovar Erika,Rodriguez-Callejas Juan D.,Cardoso-Lezama Irina^ORCID,Galindo-Gómez Silvia,Gil-Becerril Karla,Vásquez-Garzón Verónica Rocío^ORCID,Arellanes-Robledo Jaime,Tsutsumi Víctor,Villa-Treviño Saúl,Muriel Pablo^ORCID

Publisher

Elsevier BV

Subject

Hepatology,General Medicine

Reference43 articles.

1. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease;Perumpail;World J Gastroenterol,2017

2. NASH: the emerging most common form of chronic liver disease;Tesfay;Mo Med,2018

3. Models of nonalcoholic steatohepatitis potentiated by chemical inducers leading to hepatocellular carcinoma;Márquez-Quiroga;Biochem Pharmacol,2022

4. Mechanisms of fibrosis development in nonalcoholic steatohepatitis;Schwabe;Gastroenterology,2020

5. Mechanisms of NAFLD development and therapeutic strategies;Friedman;Nat Med,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The importance of fundamental pharmacology in fighting liver diseases;Annals of Hepatology;2024-03

2. Nicotinic acid attenuates experimental non-alcoholic steatohepatitis by inhibiting the NLRP3 inflammasome/pyroptosis pathway;Biochemical Pharmacology;2023-10

3. Genomic medicine in hepatology: Towards personalized medicine in obesity and chronic liver disease;Annals of Hepatology;2023-01